Skip to content

Lung Cancer Blog

Everything about lung cancer is here.

Menu
  • Home
  • About Us
  • Lung Cancer
    • Lung Cancer News
    • Causes of Lung Cancer
    • Lung Cancer Symptoms
    • Types of Lung Cancer
    • Stages of Lung Cancer
    • Lung Cancer Treatment
    • Lung Cancer Drugs
    • Lung Cancer In Ayurveda
    • Chinese Herbs For Lung Cancer
  • Researches
  • Studies
  • Stories
  • Sitemap
  • Contact Us
Menu
Lung Cancer Treatment

Lovelace Biomedical Provides New Formulation for Lung Cancer Treatment

Posted on December 14, 2020
Post Views: 401

Lung Cancer TreatmentLung Cancer is a deadly disease taking away lives of hundreds of people every year. More and more studies and researches are being conducted in the arena for treatment of lung cancer. Many organizations and teams are working towards new formulations for the treatment.

Lovelace Biomedical is a non-profit contract research organization that conducts health effects research and helps pharmaceutical companies to advance their drug development studies from preclinical stage to the clinical trials. Lovelace Biomedical; in collaboration with Lonza; has developed and advanced a novel formulation for 5-azacytidine for treatment of lung cancer. Their recent pharmacokinetic and pharmacology research has showed inhaled 5-AZA dry powder formulation had a significant effect in rat model of epigenetic lung cancer treatment. A stable dry powder formulation of 5AZA was developed due to ineffectiveness of epigenetic therapy through demethylation of 5-methylcytosine.

In this study, inhaled dry powder 5AZA showed superior pharmacokinetic properties in lung, brain, blood and liver as compared to the injected formulation and for all tissues except lung. These findings could lead to use of this drug as the first inhaled dry powder therapeutic for treatment of local and metastatic lung cancer. It can be used for adjuvant therapy as well as in combination with immunotherapy for improvement in patients’ survival rate. This work has been published in the British Journal of Cancer and is being presented at Drug Delivery to the Lung in Edinburgh.

Dr. Steve Belinsky, the lead scientist on the publication said, “Lung cancer is a devastating disease with current standard of care only providing modest improvement for patients.  The advanced approach of delivery to the lung with a novel and patented formulation that also enters the blood for delivery to other tissues improves the potential of applying epigenetic therapy to treat lung and accompanying metastatic disease.”

 

The information shared in this blog is for educational purposes only. If you face any health issues, please contact your healthcare practitioner immediately.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Telegram (Opens in new window) Telegram

Like this:

Like Loading...

Subscribe Us

Popular Articles

  • Lung Cancer Treatment in Ayurveda (7,324)
  • Lung Cancer: Symptoms and Treatment (5,655)
  • What is Non-Small-Cell Lung Cancer? (5,551)

Recent Comments

  • Lung Cancer on New Study To Help Advance Research In Lung Cancer
  • Laurie B Grimes on New Study To Help Advance Research In Lung Cancer
  • Lung Cancer on Asbestos and Lung Cancer – What’s The Link?

Recent Articles

  • Study: Wildfire Smoke Exposure Affects Lung Cancer Survival June 2, 2025
  • Predicting Lung Cancer Risk with AI based Deep Learning Model May 26, 2025
  • FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC May 19, 2025
  • Heart-Sparing Technique in Lung Cancer Radiotherapy May 12, 2025
  • Origins of Common Lung Cancer Linked to Smoking Discovered May 5, 2025

Lung Cancer Blog

Lung Cancer Blog provides all lung cancer related information for educational purposes.

Disclaimer

Some post may contain affiliate links, purchasing that product not going to cost extra but by your purchase Lung Cancer will get some little commission and that amount will help in surviving this website. So, please don’t hesitate to buy from these affiliate links.

Contact Us

If you have any query or suggestions about our blog, please feel free to email us at  lungcancersymptomsx@gmail.com.

Copyright © 2012 - 2025 Lung Cancer Blog. Wordpress by Vipasha.
  • Privacy Policy
  • About Us
  • Sitemap
  • Contact Us
%d